This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

British Journal of Pharmacology


Pharmacological impact of antiretroviral therapy on platelet function to investigate human immunodeficiency virus‐associated cardiovascular risk

Pages: 879-889

Article date: April 2019

Authors: Kirk A. Taylor, Erica Smyth, Francesca Rauzi, Maddalena Cerrone, Akif A. Khawaja, Brian Gazzard, Mark Nelson, Marta Boffito, Michael Emerson

Inhibition of Cav3.2 calcium channels: A new target for colonic hypersensitivity associated with low‐grade inflammation

Pages: 950-963

Article date: April 2019

Authors: Elodie Picard, Frederic Antonio Carvalho, Francina Agosti, Emmanuel Bourinet, Denis Ardid, Alain Eschalier, Laurence Daulhac, Christophe Mallet

Vasoactive intestinal peptide shapes first‐trimester placenta trophoblast, vascular, and immune cell cooperation

Pages: 964-980

Article date: April 2019

Authors: Daniel E. Paparini, Ruhul H. Choudhury, Daiana M. Vota, Magdalena Karolczak‐Bayatti, Sarah Finn‐Sell, Esteban N. Grasso, Vanesa C. Hauk, Rosanna Ramhorst, Claudia Pérez Leirós, John D. Aplin


Pages: 981-981

Article date: April 2019

Betulinic acid alleviates endoplasmic reticulum stress‐mediated nonalcoholic fatty liver disease through activation of farnesoid X receptors in mice

Pages: 847-863

Article date: April 2019

Authors: Ming Gu, Ping Zhao, Shiying Zhang, Shengjie Fan, Li Yang, Qingchun Tong, Guang Ji, Cheng Huang

Salvation of the fallen angel: Reactivating mutant p53

Pages: 817-831

Article date: April 2019

Authors: Yang Li, Zhuoyi Wang, Yuchen Chen, Robert B. Petersen, Ling Zheng, Kun Huang

Issue Information

Pages: 815-816

Article date: April 2019

Probe dependence of allosteric enhancers on the binding affinity of adenosine A1‐receptor agonists at rat and human A1‐receptors measured using NanoBRET

Pages: 864-878

Article date: April 2019

Authors: Samantha L. Cooper, Mark Soave, Manuela Jörg, Peter J. Scammells, Jeanette Woolard, Stephen J. Hill

Activation of RyR2 by class I kinase inhibitors

Pages: 773-786

Article date: March 2019

Authors: A D Chakraborty, L A Gonano, M L Munro, L J Smith, C Thekkedam, V Staudacher, A B Gamble, N Macquaide, A F Dulhunty, P P Jones